References
Clark, O.H., Gerend, P.L., Goretzki, P., Nissenson, R.A.: Characterization of the TSH receptor-adenylate cyclase system in neoplastic human thyroid tissue. J. Clin. Endocrinol. Metab.57:140, 1983
Fradkin, J.E., Cook, G.H., Kilhoffer, M.C., Wolff, J.: Forskolin stimulation of thyroid adenylate cyclase and cyclic 3′, 5′-adenosine monophosphate accumulation. Endocrinology111:849, 1982
Clark, O.H., Gerend, M.A., Nissenson, R.A.: Mechanisms for increased adenylate cyclase responsiveness to TSH in neoplastic human thyroid tissue. World J. Surg.8:466, 1984
Abe, Y., Ichikawa, Y., Muraki, T., et al: Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: Absence of high-affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma. J. Clin. Endocrinol. Metab.52:23, 1981
Carayon, P., Thomas-Morvan, C., Castanas, E., Tubiana, M.: Human thyroid cancer: Membrane thyrotropin binding and adenylate cyclase activity. J. Clin. Endocrinol. Metab.51:915, 1980
Shimaoka, K., Sokal, J.E.: Suppressive therapy of non-toxic goitre. Am. J. Med.57:576, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clark, O.H. Invited commentary. World J. Surg. 8, 450–451 (1984). https://doi.org/10.1007/BF01654910
Issue Date:
DOI: https://doi.org/10.1007/BF01654910